documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
210 rows where docket_id = "FDA-2017-N-6189" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-N-6189-7939 | FDA | None FDA-2017-N-6189 | Ref. 85_Donny_2015_Randomized trial of reduced-nicotine standard for cigarettes | Supporting & Related Material | Background Material | 2018-08-21T04:00:00Z | 2018 | 8 | 2018-08-21T18:52:20Z | 0 | 0 | 0900006483640913 | |||
| FDA-2017-N-6189-0650 | FDA | None FDA-2017-N-6189 | Tobacco Product Standard for Nicotine Level of Combusted Cigarettes; Extension of Comment Period | Proposed Rule | Extension of Comment Period | 2018-06-08T04:00:00Z | 2018 | 6 | 2018-06-08T04:00:00Z | 2018-07-16T08:46:05Z | 2018-12368 | 0 | 0 | 09000064833985aa | |
| FDA-2017-N-6189-0534 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from U.S. Tobacco Cooperative Inc. | Other | Request for Extension | 2018-05-24T04:00:00Z | 2018 | 5 | 2018-05-24T04:00:00Z | 2018-05-24T13:25:40Z | 0 | 0 | 09000064832c481d | ||
| FDA-2017-N-6189-0531 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from The Heritage Foundation | Other | Request for Extension | 2018-05-23T04:00:00Z | 2018 | 5 | 2018-05-23T04:00:00Z | 2018-05-23T14:11:04Z | 0 | 0 | 09000064832c0e59 | ||
| FDA-2017-N-6189-0527 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from The Heartland Institute | Other | Electronic Regulation from Form | 2018-05-22T04:00:00Z | 2018 | 5 | 2018-05-22T04:00:00Z | 2018-05-22T20:00:15Z | 0 | 0 | 09000064832b2752 | ||
| FDA-2017-N-6189-0484 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period form Kentucky Farm Bureau Federation | Other | Request for Extension | 2018-05-18T04:00:00Z | 2018 | 5 | 2018-05-18T04:00:00Z | 2018-05-18T11:47:45Z | 0 | 0 | 0900006483279624 | ||
| FDA-2017-N-6189-0470 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from Commonwealth of Virginia Department of Agriculture and Consumer Services | Other | Request for Extension | 2018-05-15T04:00:00Z | 2018 | 5 | 2018-05-15T04:00:00Z | 2018-05-15T12:10:46Z | 0 | 0 | 090000648325d390 | ||
| FDA-2017-N-6189-0459 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from ITG Brands | Other | Request for Extension | 2018-05-11T04:00:00Z | 2018 | 5 | 2018-05-11T04:00:00Z | 2018-05-11T17:37:30Z | 0 | 0 | 090000648325ad95 | ||
| FDA-2017-N-6189-0458 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from North Carolina Department of Agriculture and Consumer Services Agricultural Services | Other | Request for Extension | 2018-05-11T04:00:00Z | 2018 | 5 | 2018-05-11T04:00:00Z | 2018-05-11T17:37:57Z | 0 | 0 | 09000064832591e3 | ||
| FDA-2017-N-6189-0455 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from R Street Institute | Other | Request for Extension | 2018-05-11T04:00:00Z | 2018 | 5 | 2018-05-11T04:00:00Z | 2018-05-11T17:18:47Z | 0 | 0 | 090000648325586e | ||
| FDA-2017-N-6189-0430 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from Universal Corporation | Other | Electronic Regulation from Form | 2018-05-08T04:00:00Z | 2018 | 5 | 2018-05-08T04:00:00Z | 2018-05-08T12:16:33Z | 0 | 0 | 09000064832234ff | ||
| FDA-2017-N-6189-0429 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from Altria Client Services LLC | Other | Electronic Regulation from Form | 2018-05-08T04:00:00Z | 2018 | 5 | 2018-05-08T04:00:00Z | 2018-05-08T12:16:26Z | 0 | 0 | 09000064832236b9 | ||
| FDA-2017-N-6189-0433 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from Virginia Farm Bureau Federation | Other | Electronic Regulation from Form | 2018-05-08T04:00:00Z | 2018 | 5 | 2018-05-08T04:00:00Z | 2018-05-08T12:17:06Z | 0 | 0 | 09000064832282bb | ||
| FDA-2017-N-6189-0403 | FDA | None FDA-2017-N-6189 | Nicotine Level ANPRM as Submitted to OMB Tab A of Direction to add documents to the docket in accordance with EO 12866 | Other | Draft | 2018-04-27T04:00:00Z | 2018 | 4 | 2018-04-27T04:00:00Z | 2018-04-27T12:01:25Z | 0 | 0 | 09000064831e9654 | ||
| FDA-2017-N-6189-0405 | FDA | None FDA-2017-N-6189 | Nicotine Level ANPRM as Cleared by OMB Tab C of Direction to add documents to the docket in accordance with EO 12866 | Other | Draft | 2018-04-27T04:00:00Z | 2018 | 4 | 2018-04-27T04:00:00Z | 2018-04-27T12:01:41Z | 0 | 0 | 09000064831e9656 | ||
| FDA-2017-N-6189-0404 | FDA | None FDA-2017-N-6189 | Nicotine Level ANPRM Track Changes Tab B of Direction to add documents to the docket in accordance with EO 12866 | Other | Draft | 2018-04-27T04:00:00Z | 2018 | 4 | 2018-04-27T04:00:00Z | 2018-04-27T12:01:32Z | 0 | 0 | 09000064831e9655 | ||
| FDA-2017-N-6189-0402 | FDA | None FDA-2017-N-6189 | Memorandum to FDA DMS on Nicotine Level ANPRM | Other | Action Memo or Letter | 2018-04-27T04:00:00Z | 2018 | 4 | 2018-04-27T04:00:00Z | 2018-04-27T12:01:20Z | 0 | 0 | 09000064831e9653 | ||
| FDA-2017-N-6189-0407 | FDA | None FDA-2017-N-6189 | Extension of Comment Period from North Carolina Farm Bureau Federation, Inc. | Other | Electronic Regulation from Form | 2018-04-27T04:00:00Z | 2018 | 4 | 2018-04-27T04:00:00Z | 2018-04-27T15:41:36Z | 0 | 0 | 09000064831ecc6f | ||
| FDA-2017-N-6189-0389 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from The Council for Burley Tobacco | Other | Request for Extension | 2018-04-26T04:00:00Z | 2018 | 4 | 2018-04-26T04:00:00Z | 2018-04-26T14:28:46Z | 0 | 0 | 09000064831c5edb | ||
| FDA-2017-N-6189-0208 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from National Association of Tobacco Outlets, Inc. | Other | Request for Extension | 2018-04-18T04:00:00Z | 2018 | 4 | 2018-04-18T04:00:00Z | 2018-04-19T02:01:31Z | 0 | 0 | 0900006483145105 | ||
| FDA-2017-N-6189-0210 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from Convenience Distribution Association | Other | Request for Extension | 2018-04-18T04:00:00Z | 2018 | 4 | 2018-04-18T04:00:00Z | 2018-04-19T02:27:16Z | 0 | 0 | 0900006483173fda | ||
| FDA-2017-N-6189-0205 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from | Other | Electronic Regulation from Form | 2018-04-18T04:00:00Z | 2018 | 4 | 2018-04-18T04:00:00Z | 2018-04-19T00:56:59Z | 0 | 0 | 090000648305ba71 | ||
| FDA-2017-N-6189-0204 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from Altria Client Services | Other | Request for Extension | 2018-04-18T04:00:00Z | 2018 | 4 | 2018-04-18T04:00:00Z | 2018-04-18T23:28:32Z | 0 | 0 | 090000648303edba | ||
| FDA-2017-N-6189-0209 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from The Heartland Institute | Other | Request for Extension | 2018-04-18T04:00:00Z | 2018 | 4 | 2018-04-18T04:00:00Z | 2018-04-19T02:20:12Z | 0 | 0 | 090000648314fa61 | ||
| FDA-2017-N-6189-0207 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from RAI Services Company | Other | Request for Extension | 2018-04-18T04:00:00Z | 2018 | 4 | 2018-04-18T04:00:00Z | 2018-04-19T01:56:22Z | 0 | 0 | 090000648304ef16 | ||
| FDA-2017-N-6189-0206 | FDA | None FDA-2017-N-6189 | Request for Extension of Comment Period from Altria Client Services | Other | Request for Extension | 2018-04-18T04:00:00Z | 2018 | 4 | 2018-04-18T04:00:00Z | 2018-04-19T01:26:04Z | 0 | 0 | 09000064830854b5 | ||
| FDA-2017-N-6189-0079 | FDA | None FDA-2017-N-6189 | Reference 111_Lindson_2010_Reduction Versus Abrupt Cessation in Smokers Who Want to Quit | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:21Z | 0 | 0 | 0900006483017c78 | |||
| FDA-2017-N-6189-0164 | FDA | None FDA-2017-N-6189 | Reference 116_CRM_2005_Determination of Nicotine in Tobacco and Tobacco Products by Gas Chromatographic Analysis | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:55:08Z | 0 | 0 | 0900006483017c7d | |||
| FDA-2017-N-6189-0102 | FDA | None FDA-2017-N-6189 | Reference 123_NRP_1989_Nicotine Reduction Program | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:36Z | 0 | 0 | 0900006483017c8a | |||
| FDA-2017-N-6189-0100 | FDA | None FDA-2017-N-6189 | Reference 125_Ding_2017_Chemical Characterization of Mainstream Smoke from Spectrum Variable Nicotine Research Cigarettes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:35Z | 0 | 0 | 0900006483017c8c | |||
| FDA-2017-N-6189-0096 | FDA | None FDA-2017-N-6189 | Reference 129_Har_Monthly Project Development Report | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:32Z | 0 | 0 | 0900006483017c97 | |||
| FDA-2017-N-6189-0111 | FDA | None FDA-2017-N-6189 | Reference 151_Boswall_1971_Project T-6534 Tobacco for Reconstitution | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:44Z | 0 | 0 | 0900006483017cc0 | |||
| FDA-2017-N-6189-0172 | FDA | None FDA-2017-N-6189 | Reference 80_Counts l_2005_Smoke composition and predicting realtionships for international commercial cigarettes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:56:35Z | 0 | 0 | 0900006483017dc0 | |||
| FDA-2017-N-6189-0083 | FDA | None FDA-2017-N-6189 | Reference 107_Rose 06_Precessation Treatment with Nicotine Skin Patch Facilitates Smoking Cessation | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:24Z | 0 | 0 | 0900006483017e38 | |||
| FDA-2017-N-6189-0138 | FDA | None FDA-2017-N-6189 | Reference 161_Hash_2014_Reducing Levels of Nicotinice Alkaloids in Plants | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:53:03Z | 0 | 0 | 0900006483017eb2 | |||
| FDA-2017-N-6189-0134 | FDA | None FDA-2017-N-6189 | Reference 165_Ridomil_800000 D.R.S. Ridomil Experiment | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:53:01Z | 0 | 0 | 0900006483017eca | |||
| FDA-2017-N-6189-0016 | FDA | None FDA-2017-N-6189 | Reference 5_Ben 07_Nicotine and Carcinogen Exposure With Smoking of Progressively Reduced Nicotine Content Cigarettes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:27Z | 0 | 0 | 0900006483017bc9 | |||
| FDA-2017-N-6189-0003 | FDA | None FDA-2017-N-6189 | Reference 18_Lenk_2014_Do Sources of Cigarettes Among Adolescents Vary by Age Over Time | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:19Z | 0 | 0 | 0900006483017bfc | |||
| FDA-2017-N-6189-0031 | FDA | None FDA-2017-N-6189 | Reference 29_Fong_2004_The Near-Universal Experience of Regret Among Smokers in Four Countries Findings From the International Tobacco Control Policy | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:36Z | 0 | 0 | 0900006483017c23 | |||
| FDA-2017-N-6189-0028 | FDA | None FDA-2017-N-6189 | Reference 32_Christensen_2018_StudyAssociation of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:35Z | 0 | 0 | 0900006483017c2c | |||
| FDA-2017-N-6189-0024 | FDA | None FDA-2017-N-6189 | Reference 36_94 SG_Youth & Tobacco Preventing Tobacco Use Among Young People | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:32Z | 0 | 0 | 0900006483017c33 | |||
| FDA-2017-N-6189-0165 | FDA | None FDA-2017-N-6189 | Reference 79_ART_Alkaloid Reduced Tobacco | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:55:09Z | 0 | 0 | 0900006483017dbf | |||
| FDA-2017-N-6189-0082 | FDA | None FDA-2017-N-6189 | Reference 108_Walker 12_The Combined Effect of Very Low Nicotine Content Cigarettes, Used as an Adjunct to Usual Quitline Care | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:23Z | 0 | 0 | 0900006483017e39 | |||
| FDA-2017-N-6189-0097 | FDA | None FDA-2017-N-6189 | Reference 128_Wayne_2012_Tobacco Industry Research on Modification of Nicotine Content in Tobacco | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:33Z | 0 | 0 | 0900006483017c8f | |||
| FDA-2017-N-6189-0123 | FDA | None FDA-2017-N-6189 | Reference 139_Crouse_1987_Communication with Michael Ogden RJR Bowman Gray Development Center | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:54Z | 0 | 0 | 0900006483017ca9 | |||
| FDA-2017-N-6189-0115 | FDA | None FDA-2017-N-6189 | Reference 147_Hempfling_1987_Philip Morris and the New Biotechnology | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:48Z | 0 | 0 | 0900006483017cbc | |||
| FDA-2017-N-6189-0051 | FDA | None FDA-2017-N-6189 | Reference 47_CDC 5708_2008_Surveillance for cancers associated with tobacco use-United States_1999-2004 | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:50Z | 0 | 0 | 0900006483017d4e | |||
| FDA-2017-N-6189-0044 | FDA | None FDA-2017-N-6189 | Reference 54_Henn 98_Reducing the Addictiveness of Cigarettes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:45Z | 0 | 0 | 0900006483017d7a | |||
| FDA-2017-N-6189-0166 | FDA | None FDA-2017-N-6189 | Reference 78_NIH_Notice of Availability of Nicotine Research Cigarettes Through NIDA’s Drug Supply Program | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:55:10Z | 0 | 0 | 0900006483017dbe | |||
| FDA-2017-N-6189-0008 | FDA | None FDA-2017-N-6189 | Reference 13_IOM 07_2007_Ending the Tobacco Problem A Blueprint for the Nation | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:23Z | 0 | 0 | 09000064830178c1 | |||
| FDA-2017-N-6189-0130 | FDA | None FDA-2017-N-6189 | Reference 169_Geiss 75_Bw Process VI Metabolism of Nicotine and Other Biochemistry of the Bw Process | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:59Z | 0 | 0 | 0900006483017ece | |||
| FDA-2017-N-6189-0015 | FDA | None FDA-2017-N-6189 | Reference 6_NEJM_2015_Smoking and Mortality Beyond Established Causes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:26Z | 0 | 0 | 0900006483017bca | |||
| FDA-2017-N-6189-0022 | FDA | None FDA-2017-N-6189 | Reference 38_Choi_1997_Which Adolescent Experimenters Progress to Established Smoking in the United States | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:31Z | 0 | 0 | 0900006483017c35 | |||
| FDA-2017-N-6189-0109 | FDA | None FDA-2017-N-6189 | Reference 152_Evans_1971_Low Nicotine Tobacco | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:42Z | 0 | 0 | 0900006483017cc1 | |||
| FDA-2017-N-6189-0084 | FDA | None FDA-2017-N-6189 | Reference 106_Hats Kot 10_Reduced Nicotine Content Cigarettes Effects on Toxicant Exposure Dependence and Cessation | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:25Z | 0 | 0 | 0900006483017e37 | |||
| FDA-2017-N-6189-0076 | FDA | None FDA-2017-N-6189 | Reference 114_TobLab_2014_Standard operating procedure for determination of nicotine in cigarette tobacco filler | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:20Z | 0 | 0 | 0900006483017c7b | |||
| FDA-2017-N-6189-0161 | FDA | None FDA-2017-N-6189 | Reference 133_Dunsby_2004_A nicotine delivery device without the nicotine Tobacco industry development of low nicotine cigarettes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:55:06Z | 0 | 0 | 0900006483017c9c | |||
| FDA-2017-N-6189-0160 | FDA | None FDA-2017-N-6189 | Reference 134_Tso 1972_The Potential for Producing Safer Cigarette Tobacco | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:55:06Z | 0 | 0 | 0900006483017c9d | |||
| FDA-2017-N-6189-0087 | FDA | None FDA-2017-N-6189 | Reference 103_Benowitz 2006_Nicotine Intake and Dose Response When Smoking Reduced-Nicotine Content Cigarettes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:26Z | 0 | 0 | 0900006483017e34 | |||
| FDA-2017-N-6189-0019 | FDA | None FDA-2017-N-6189 | Reference 2_Ben 13_Reducing the nicotine content to make cigarettes less addictive | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:29Z | 0 | 0 | 0900006483017bc6 | |||
| FDA-2017-N-6189-0004 | FDA | None FDA-2017-N-6189 | Reference 17_10 SG_How Tobacco Smoke Causes Disease The Biology and Behavioral Basis for Smoking-Attributable Disease | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:20Z | 0 | 0 | 0900006483017bfa | |||
| FDA-2017-N-6189-0027 | FDA | None FDA-2017-N-6189 | Reference 33_Rodriguez_2010_The Association of Pipe and Cigar Use With Cotinine Levels, Lung Function, and Airflow Obstruction | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:34Z | 0 | 0 | 0900006483017c2f | |||
| FDA-2017-N-6189-0070 | FDA | None FDA-2017-N-6189 | Reference 63_Fiore 15_Reduced-nicotine cigarettes_A promising regulatory pathway | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:02Z | 0 | 0 | 0900006483017c56 | |||
| FDA-2017-N-6189-0062 | FDA | None FDA-2017-N-6189 | Reference 71_Jacob_1999_Minor tobacco alkaloids as biomarkers for tobacco use | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:57Z | 0 | 0 | 0900006483017c5e | |||
| FDA-2017-N-6189-0074 | FDA | None FDA-2017-N-6189 | Reference 59_06 SG_The health consequences of involuntary exposure to tobacco smoke | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:04Z | 0 | 0 | 0900006483017d7f | |||
| FDA-2017-N-6189-0145 | FDA | None FDA-2017-N-6189 | Reference 154_BAT_1973_Research and Development Department Progress in 1972 – Plans for 1973 | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:53:06Z | 0 | 0 | 0900006483017eaa | |||
| FDA-2017-N-6189-0017 | FDA | None FDA-2017-N-6189 | Reference 4_Hats 10_Reduced Nicotine Content Cigarettes Effects on Toxic Exposure, Dependence, and Cessation | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:28Z | 0 | 0 | 0900006483017bc8 | |||
| FDA-2017-N-6189-0039 | FDA | None FDA-2017-N-6189 | Reference 21_CDC 6044_2011_Quitting Smoking Among Adults United States 2001- 2010 | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:41Z | 0 | 0 | 0900006483017bff | |||
| FDA-2017-N-6189-0025 | FDA | None FDA-2017-N-6189 | Reference 35_Weglicki_2008_Tobacco Use Assessment What Exactly Is Your Patient Using and Why Is It Important to Know | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:33Z | 0 | 0 | 0900006483017c31 | |||
| FDA-2017-N-6189-0068 | FDA | None FDA-2017-N-6189 | Reference 65_Scherer_1999_Smoking behaviour and compensation-a review of the literature | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:01Z | 0 | 0 | 0900006483017c58 | |||
| FDA-2017-N-6189-0067 | FDA | None FDA-2017-N-6189 | Reference 66_Grubbs_1991_Process for removal of basic materials | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:00Z | 0 | 0 | 0900006483017c59 | |||
| FDA-2017-N-6189-0148 | FDA | None FDA-2017-N-6189 | Reference 173_90 SG_1990_The Health Benefits of Smoking Cessation | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:53:13Z | 0 | 0 | 0900006483017cdf | |||
| FDA-2017-N-6189-0153 | FDA | None FDA-2017-N-6189 | Reference 178_Taylor_2002_Benefits of Smoking Cessation for Longevity_AJPH | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:53:16Z | 0 | 0 | 0900006483017ce5 | |||
| FDA-2017-N-6189-0060 | FDA | None FDA-2017-N-6189 | Reference 73_Djordjevic_1990_CORESTA Symposium, Kallithea Greece | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:56Z | 0 | 0 | 0900006483017db8 | |||
| FDA-2017-N-6189-0171 | FDA | None FDA-2017-N-6189 | Reference 77_Patent_Reducing Levels of Nicotinic Alkaloids in Plants | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:56:27Z | 0 | 0 | 0900006483017dbd | |||
| FDA-2017-N-6189-0129 | FDA | None FDA-2017-N-6189 | Reference 170_Gravely_1973_Bw Process IV Evaluation of Low Nicotine Cigarettes Use for Consumer Product Testing | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:58Z | 0 | 0 | 0900006483017ecf | |||
| FDA-2017-N-6189-0158 | FDA | None FDA-2017-N-6189 | Reference 93_Perkins_2008_Mood Influences on Acute Smoking Responses Are Independent of Nicotine Intake and Dose Expectancy | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:55:03Z | 0 | 0 | 0900006483017c68 | |||
| FDA-2017-N-6189-0184 | FDA | None FDA-2017-N-6189 | Reference 94_Gross_1997_Nicotine Containing Versus De Nicotinized Cigarettes Effects on Craving and Withdrawal | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T16:03:58Z | 0 | 0 | 0900006483017c69 | |||
| FDA-2017-N-6189-0091 | FDA | None FDA-2017-N-6189 | Reference 99_Wu_2002_Determination of Nicotine and Other Minor Alkaloids in International Cigarettes by Solid Phase Microextraction and Gas Chromatography Mass | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:29Z | 0 | 0 | 0900006483017c6f | |||
| FDA-2017-N-6189-0108 | FDA | None FDA-2017-N-6189 | Reference 117_Wu 98_Analytical Determination of Nicotine in Tobacco by Supercritical Fluid Chromatography−Ion Mobility Detection | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:41Z | 0 | 0 | 0900006483017c7e | |||
| FDA-2017-N-6189-0099 | FDA | None FDA-2017-N-6189 | Reference 126_Mon.7_The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of U.S. Cigarettes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:34Z | 0 | 0 | 0900006483017c8d | |||
| FDA-2017-N-6189-0095 | FDA | None FDA-2017-N-6189 | Reference 130_unnamed_2016_Unnamed Report | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:31Z | 0 | 0 | 0900006483017c98 | |||
| FDA-2017-N-6189-0126 | FDA | None FDA-2017-N-6189 | Reference 136_Borriston_1984_. Final Report 14-Day Single Dose Subacute Toxicity Study in the Rat With A-7 Borriston Project | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:57Z | 0 | 0 | 0900006483017c9f | |||
| FDA-2017-N-6189-0120 | FDA | None FDA-2017-N-6189 | Reference 142_Roselius_1879_Process for the Extraction of Nicotine From Tobacco | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:52Z | 0 | 0 | 0900006483017caf | |||
| FDA-2017-N-6189-0113 | FDA | None FDA-2017-N-6189 | Reference 149_Sensa_1992_Sensa Business Plan Executive Summary | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:46Z | 0 | 0 | 0900006483017cbe | |||
| FDA-2017-N-6189-0047 | FDA | None FDA-2017-N-6189 | Reference 51_Kenford_1994_Predicting Smoking Cessation Who Will Quit With and Without the Nicotine Patch | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:47Z | 0 | 0 | 0900006483017d52 | |||
| FDA-2017-N-6189-0176 | FDA | None FDA-2017-N-6189 | Reference 84_Sof rev_2012_The reinforcement threshold for nicotine as a target for tobacco control | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:58:32Z | 0 | 0 | 0900006483017df4 | |||
| FDA-2017-N-6189-0182 | FDA | None FDA-2017-N-6189 | Reference 90_Eid_2005_Placebo cigarettes in a spaced smoking paradigm | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T16:02:48Z | 0 | 0 | 0900006483017dfa | |||
| FDA-2017-N-6189-0131 | FDA | None FDA-2017-N-6189 | Reference 168_Geiss_1972_Bw Process I Reductions of Tobacco Nicotine Using Selected Bacteria | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:59Z | 0 | 0 | 0900006483017ecd | |||
| FDA-2017-N-6189-0009 | FDA | None FDA-2017-N-6189 | Reference 12_Johnston 2005_Monitoring the Future national survey results on drug use 1975-2004 | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:23Z | 0 | 0 | 09000064830178c0 | |||
| FDA-2017-N-6189-0021 | FDA | None FDA-2017-N-6189 | Reference List_Tobacco Product Standard for Nicotine Level of Combusted Cigarettes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:30Z | 0 | 0 | 0900006483017bc4 | |||
| FDA-2017-N-6189-0018 | FDA | None FDA-2017-N-6189 | Reference 3_Hats Heis 13_Dose Response Effects of Spectrum Research Cigarettes | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:28Z | 0 | 0 | 0900006483017bc7 | |||
| FDA-2017-N-6189-0040 | FDA | None FDA-2017-N-6189 | Reference 20_Grucza_2013_Long-Term Effects of Laws Governing Youth Access to Tobacco | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:42Z | 0 | 0 | 0900006483017bfe | |||
| FDA-2017-N-6189-0173 | FDA | None FDA-2017-N-6189 | Reference 81_B&H 94_Establishing a nicotine threshold for addiction - the implications for tobacco regulation | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:56:40Z | 0 | 0 | 0900006483017df1 | |||
| FDA-2017-N-6189-0139 | FDA | None FDA-2017-N-6189 | Ref. 160_Cohen_1971_Minutes of Meeting on May 6, 1971 | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:53:03Z | 0 | 0 | 0900006483017eb0 | |||
| FDA-2017-N-6189-0098 | FDA | None FDA-2017-N-6189 | Reference 127_Farone_U.S. District Court for the District of Columbia United States of America, Plaintiff, versus Philip Morris, USA, et al., defendants | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:34Z | 0 | 0 | 0900006483017c8e | |||
| FDA-2017-N-6189-0124 | FDA | None FDA-2017-N-6189 | Reference 138_PM_Untitled Chart | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:55Z | 0 | 0 | 0900006483017ca8 | |||
| FDA-2017-N-6189-0122 | FDA | None FDA-2017-N-6189 | Reference 140_Ruiz_2008_Supercritical Fluid Extraction of Tobacco Leaves A Preliminary Study on the Extraction of Solanesol | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:53Z | 0 | 0 | 0900006483017caa | |||
| FDA-2017-N-6189-0118 | FDA | None FDA-2017-N-6189 | Reference 144_Crouse 76_Nicotine Extraction Preliminary Study of Methods for High Nicotine Leaf Extraction June 20 1976 | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:52:51Z | 0 | 0 | 0900006483017cb1 | |||
| FDA-2017-N-6189-0053 | FDA | None FDA-2017-N-6189 | Reference 45_Chaiton_2016_Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers | Supporting & Related Material | Background Material | 2018-03-16T04:00:00Z | 2018 | 3 | 2018-03-16T15:51:51Z | 0 | 0 | 0900006483017d4c |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;